34 research outputs found

    Occupations and Morbidity Pattern in a North Indian Site: Need for Focused Health Services for House Wife, Pensioners and Unemployed

    Get PDF
    Background: Morbidity has factors related to occupational status, however information from community based study is seldom available in India. This article uses self reported morbidity in the community from one North Indian sites and effect of occupational status on morbidity.Methods: An ICMR Task force study of health accounting, collected different health related parameters at baseline. Under the study thousand households (500 rural, 500 urban) were surveyed during 2012-13by door to door survey using pretested questionnaire after availing written informed consent. This information reflects the distribution of demographic and occupation profile in relation to morbidities.Results: Overall self reported morbidity prevalence was nearly sixteen percent (821 out of 5279, 15.8%). 766 individuals provided details, among them 530 (12%) were considered as corroborative evidence to support disease diagnosis. Nearly 32% suffered from communicable and 67% suffered from non-communicable diseases. Among different occupations, pensioners had highest morbidities (24.5%) followed by unemployed (20.5%) and housewives (21.4%).Conclusion: Morbidity profile and effect of occupation/ work status is evident from the study. There is need of targeted services for these groups and periodic feedback or impact assessment from consumers themselves will be more authentic for appropriate policy formulation

    Tissue-specific alternative splicing of TCF7L2

    Get PDF
    Common variants in the transcription factor 7-like 2 (TCF7L2) gene have been identified as the strongest genetic risk factors for type 2 diabetes (T2D). However, the mechanisms by which these non-coding variants increase risk for T2D are not well-established. We used 13 expression assays to survey mRNA expression of multiple TCF7L2 splicing forms in up to 380 samples from eight types of human tissue (pancreas, pancreatic islets, colon, liver, monocytes, skeletal muscle, subcutaneous adipose tissue and lymphoblastoid cell lines) and observed a tissue-specific pattern of alternative splicing. We tested whether the expression of TCF7L2 splicing forms was associated with single nucleotide polymorphisms (SNPs), rs7903146 and rs12255372, located within introns 3 and 4 of the gene and most strongly associated with T2D. Expression of two splicing forms was lower in pancreatic islets with increasing counts of T2D-associated alleles of the SNPs: a ubiquitous splicing form (P = 0.018 for rs7903146 and P = 0.020 for rs12255372) and a splicing form found in pancreatic islets, pancreas and colon but not in other tissues tested here (P = 0.009 for rs12255372 and P = 0.053 for rs7903146). Expression of this form in glucose-stimulated pancreatic islets correlated with expression of proinsulin (r2 = 0.84–0.90, P < 0.00063). In summary, we identified a tissue-specific pattern of alternative splicing of TCF7L2. After adjustment for multiple tests, no association between expression of TCF7L2 in eight types of human tissue samples and T2D-associated genetic variants remained significant. Alternative splicing of TCF7L2 in pancreatic islets warrants future studies. GenBank Accession Numbers: FJ010164–FJ010174

    Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27

    No full text
    Sprouty1 (Spry1) is a conserved antagonist of FGF signaling. The goal of this study was to further explore the downstream mechanisms governing Spry1 inhibition of endothelial cell proliferation. Up-regulation of Spry1 in HUVECs inhibited tube formation on Matrigel ( n = 6, P < 0.001). This was associated with decreased proliferation as measured by BrdU incorporation ( n = 6, P 2-fold increase in an anti-angiogenic factor, serpin peptidase inhibitor, clad F (Serpinf1), and a >2-fold decrease in pro-angiogenic factors fms-related tyrosine kinase 1 (FLT1), angiopoietin2 (Ang-2), and placental growth factor (PGF) ( n = 2). To define upstream mechanisms that may regulate endogenous Spry1, we performed a search for responsive elements upstream of the promoter region. This search resulted in the identification of multiple degenerate hypoxia responsive elements. Exposure to hypoxia resulted in a significant increase in Spry1 expression ( n = 8, P < 0.01). These findings shed new light on downstream signaling pathways associated with Spry1 anti-proliferative responses, and provide new evidence that hypoxia stimulates Spry1 expression

    Identification of Differentially Expressed Transcripts and Pathways in Blood One Week and Six Months Following Implant of Left Ventricular Assist Devices

    Get PDF
    <div><p>Introduction</p><p>Continuous-flow left ventricular assist devices (LVADs) are an established therapy for patients with end-stage heart failure. The short- and long-term impact of these devices on peripheral blood gene expression has not been characterized, and may provide insight into the molecular pathways mediated in response to left ventricular remodeling and an improvement in overall systemic circulation. We performed RNA sequencing to identify genes and pathways influenced by these devices.</p> <p>Methods</p><p>RNA was extracted from blood of 9 heart failure patients (8 male) prior to LVAD implantation, and at 7 and 180 days postoperatively. Libraries were sequenced on an Illumina HiSeq2000 and sequences mapped to the human Ensembl GRCh37.67 genome assembly.</p> <p>Results</p><p>A specific set of genes involved in regulating cellular immune response, antigen presentation, and T cell activation and survival were down-regulated 7 days after LVAD placement. 6 months following LVAD placement, the expression levels of these genes were significantly increased; yet importantly, remained significantly lower than age and sex-matched samples from healthy controls.</p> <p>Conclusions</p><p>In summary, this genomic analysis identified a significant decrease in the expression of genes that promote a healthy immune response in patients with heart failure that was partially restored 6 months following LVAD implant.</p> </div
    corecore